SERO Serologicals (MM)

Serologicals Corporation (NASDAQ: SERO) announced today that Serologicals President and CEO David A. Dodd will be the featured speaker on November 16, 2005 at the J. Mack Robinson College of Business at Georgia State University. He will be taking part in the Atlanta Business Leaders Speaker Series from 4:30 - 7:00 p.m. at the GSU Student Center Auditorium in Downtown Atlanta on the GSU campus. Dodd's presentation, titled "Creating a Sustainable Business," will focus on strategies for how to grow and sustain a business. He will use examples from the ongoing transformation of Serologicals Corporation into a global leader in providing research & bioprocessing products, technologies and services. During 2005, Dodd has been chosen as a "CEO Visionary" by Start Magazine, as well as receiving the 2005 Oglethorpe Award from the Atlanta Chapter of the British American Business Group, in recognition of his ongoing leadership in fostering business relationships between the U.S. and the United Kingdom. Serologicals Corporation (NASDAQ: SERO), headquartered in Atlanta, GA., is a global leader in developing and commercializing consumable biological products, enabling technologies and services in support of biological research, drug discovery, and the bioprocessing of life-enhancing products. Our customers include researchers at major life science companies and leading research institutions involved in key disciplines, such as neurology, oncology, hematology, immunology, cardiology, proteomics, infectious diseases, cell signaling and stem cell research. In addition, Serologicals is the world's leading provider of monoclonal antibodies for the blood typing industry. Serologicals employs a total of more than 1,000 people worldwide in three Serologicals' companies: Chemicon International, headquartered in Temecula, CA, Upstate Group, LLC, headquartered in Charlottesville, VA. and Celliance Corporation, headquartered in Atlanta, GA. For more information, please visit our website: www.serologicals.com.